Clinical Trial Update: Single Photon Emission Computed Tomography to Study Receptors in Parkinson's Disease

View source ↗

Summary

A completed clinical trial used single-photon emission computed tomography (SPECT) imaging to study receptor binding in Parkinson disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Snippet

Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) | Conditions: Parkinson Disease | Status: COMPLETED